Dexcom (DXCM)

Dexcom (DXCM) Financial Statements


Dexcom Financial Overview

Dexcom's market cap is currently ―. The company's EPS TTM is $0.704; its P/E ratio is 169.79; Dexcom is scheduled to report earnings on August 2, 2023, and the estimated EPS forecast is $0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 741.50M$ 815.20M$ 769.60M$ 696.20M$ 628.80M
Gross Profit$ 462.60M$ 541.30M$ 494.20M$ 449.50M$ 398.10M
EBIT$ 69.10M$ 137.90M$ 150.80M$ 80.00M$ 41.50M
EBITDA$ 70.90M$ 174.20M$ 190.00M$ 123.60M$ 78.30M
Net Income Common Stockholders$ 48.60M$ 91.80M$ 101.20M$ 50.90M$ 97.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 623.20M$ 2.46B$ 2.37B$ 2.75B$ 2.69B
Total Assets$ 5.52B$ 5.39B$ 4.90B$ 5.22B$ 5.06B
Total Debt$ 2.08B$ 2.15B$ 2.13B$ 2.14B$ 2.14B
Net Debt$ 1.46B$ -311.20M$ -239.70M$ -617.30M$ -546.50M
Total Liabilities$ 3.28B$ 3.26B$ 3.07B$ 2.96B$ 2.87B
Stockholders Equity$ 2.23B$ 2.13B$ 1.82B$ 2.26B$ 2.19B
Cash Flow-
Free Cash Flow$ 80.70M$ 69.00M$ 185.00M$ 81.30M$ -30.60M
Operating Cash Flow$ 155.40M$ 132.50M$ 293.20M$ 172.80M$ 71.00M
Investing Cash Flow$ -186.70M$ -194.10M$ 229.30M$ -144.90M$ -411.80M
Financing Cash Flow$ 11.20M$ -1.00M$ -552.50M$ -4.30M$ 5.30M
Currency in USD

Dexcom Earnings and Revenue History

Dexcom Debt to Assets

Dexcom Cash Flow

Dexcom Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis